Literature DB >> 32006907

Maladaptive daydreaming and emotional regulation difficulties: A network analysis.

Talya Greene1, Melina West2, Eli Somer3.   

Abstract

This study explored the network structure of Maladaptive Daydreaming (MD), and links between MD and emotional regulation difficulties. Participants (n = 542) completed an online survey on MD and emotional regulation difficulties. Two network models were estimated. In the MD-only network, items clustered in three communities, most items were positively connected, and difficulty controlling the daydream was most central. In the expanded network, there were many cross-construct associations, and limited emotional regulation strategies and difficulty controlling the daydream were most central. These findings indicate that difficulties with control is central to MD, and that MD may be related to dysfunctional emotional regulation.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Emotional dysregulation; Maladaptive daydreaming; Network analysis

Year:  2020        PMID: 32006907     DOI: 10.1016/j.psychres.2020.112799

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  3 in total

1.  Childhood traumatization and dissociative experiences among maladaptive and normal daydreamers in a Hungarian sample.

Authors:  Alexandra Sándor; Antal Bugán; Attila Nagy; Nikolett Nagy; Katalin Tóth-Merza; Judit Molnár
Journal:  Curr Psychol       Date:  2021-08-30

2.  Different cultures, similar daydream addiction? An examination of the cross-cultural measurement equivalence of the Maladaptive Daydreaming Scale.

Authors:  Nirit Soffer-Dudek; Eli Somer; Hisham M Abu-Rayya; Barış Metin; Adriano Schimmenti
Journal:  J Behav Addict       Date:  2020-11-02       Impact factor: 6.756

3.  Psychometric properties of the Maladaptive Daydreaming Scale in a sample of Hungarian daydreaming-prone individuals.

Authors:  Alexandra Sándor; Ákos Münnich; Judit Molnár
Journal:  J Behav Addict       Date:  2020-10-06       Impact factor: 6.756

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.